Liver iron concentration imaging
Liver iron concentration imaging is used to assess iron overload. It supports diagnosis and management of conditions such as thalassemia and hemochromatosis.
Where this biomarker is used
Each approval combines this biomarker with a specific indication and therapy. Select a therapy in the tables below to open its FDA-defined testing pathway.
Approvals where Liver iron concentration imaging is defined directly in the indication labeling.
| Indication | Biomarker criteria | Therapies |
|---|---|---|
Non-Transfusion-Dependent Thalassemia Other · Blood |
|
Approvals defined at the solid tumor level where Liver iron concentration imaging is part of the eligibility criteria.
No tumor-agnostic approvals are currently mapped for this biomarker.
Tests that measure this biomarker
These assays report Liver iron concentration imaging as part of their validated menu. In many cases they are identified in FDA labeling as acceptable companion diagnostics for specific approvals.
Reports Liver iron concentration imaging as part of its biomarker panel.